This can be the basis for a protein biopsy that can remove cysts before the cancer develops and spreads.
Scientists from the American clinic Duke Health have discovered a set of biomarkers that can significantly improve the accuracy of diagnosing pancreatic cancer. Thus, the disease can be detected at the earliest stage. Writing about it Drug Target Review.
The author of the study is Dr. Peter Allen. He and his team used digital spatial RNA profiling, and in this way identified genetic mutations in cyst areas with high and low levels of abnormal cell growth.
The team is currently working on identifying markers in the cyst fluid. This can be the basis for a protein biopsy that can remove cysts before the cancer develops and spreads.
“Modern diagnostic methods for pancreatic cancer, such as clinical, radiographic, laboratory, endoscopic and cytological analysis, have a total accuracy rate of approximately 60%. Pancreatic cancer is becoming more common, and if the current trend will continue, it will soon become the second leading cause of cancer death in the US The cause of the increased incidence is not yet known, but some research suggests that inflammation may be a contributing factor ,” Allen said.
Recall that early Chinese scientists grew “mini-horns” in mice by inserting deer genes into them.
An American’s body begins to produce alcohol
news Correspondent.net on Telegram. Subscribe to our channel Athletistic
Source: korrespondent
I am Ben Stock, a passionate and experienced digital journalist working in the news industry. At the Buna Times, I write articles covering technology developments and related topics. I strive to provide reliable information that my readers can trust. My research skills are top-notch, as well as my ability to craft engaging stories on timely topics with clarity and accuracy.